Post-Operative Pain Therapeutics Pipeline Analysis

Post-Operative Pain Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Published: July 2017
Report Code: LS11091
Available Format:
Pages: 158

Note: This report can also be updated as of date and delivered within 1-2 workings days of purchase confirmation

Disease Overview

Pain is an intricate sensation that differs in every individual, even if the cause or the injury is similar. The intensity of pain can be a dull aching or an instant sensation. It may feel like an inexplicable, irritating tickle on the skin. Pain, if left untreated for a long period, negatively impact a person’s mood and well-being. It occurs when the electrical signal travels to the spinal cord due to activation of receptors, which is then transmitted to the brain. The spinal cord acts as a transmission center, where the pain signal can be targeted by blocking, enhancing or modifying before it reaches to the brain. It involves the interaction of various chemicals, known as neurotransmitters, in the body, which together act to produce the sensation of pain. The intensity of pain can be acute or chronic depending upon the time it lasts. There are various types of pain such as nociceptive pain, inflammatory pain, pathologic pain, cancer pain, musculoskeletal pain and post-operative pain.

Post-operative pain is a very common problem after any surgery and it is necessary to treat the same effectively, so that the patient is more comfortable and positive, wounds heal better, there remains less risk for heart and lung complications, and patients are less likely to develop neuropathic pain.

Drug manufacturing companies are constantly involved in the quest to find better and new treatment strategies with potential targets such as sodium channel, opioid receptor and cyclooxygenase which can be effective in post-operative pain treatment. Various companies are developing drug candidates using advanced technologies, which is driving the growth of the pipeline.

Pipeline Analysis

As of July 2017, the post-operative pain therapeutics pipeline comprises of approximately 39 drug candidates in different stages of development.



Post-Operative Pain Therapeutics Pipeline Analysis

Competitive Landscape

Some of the key players developing drugs for post-operative pain include DURECT Corporation, Elite Pharmaceuticals, Inc., Cara Therapeutics, Inc. and others.

Scope for Customization

P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:

  • Market Forecast – Market analysis and forecast for the drug candidates in the latest stage of development
  • Company Profiles – Wider company coverage in terms of detailed analysis or additional company profiles

Place An Order

Single User License

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 2500
Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 3250
Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7000

Pre-Purchase Enquiry